Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: CARBAMAZEPINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic Carbamazepine product from Ingenus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE (CARBAMAZEPINE)